The prevalence of ALL subtypes varies in children with standard-risk (SR) ALL (age 1 to 9 years and WBC count <  50 × 109/L), children with high-risk (HR) ALL (age 10 to 15 years and/or WBC count > 50 × 109/L), and adolescents (age 16 to 20 years), young adults (age 21 to 39 years), adults (age 40 to 59 years), and older adults (age 60 to 86 years) with ALL. Other, B-cell ALL lacking recurrent abnormalities; Ph, Philadelphia chromosome. Data adapted. Reprinted from Iacobucci and Mullighan with permission.

The prevalence of ALL subtypes varies in children with standard-risk (SR) ALL (age 1 to 9 years and WBC count <  50 × 109/L), children with high-risk (HR) ALL (age 10 to 15 years and/or WBC count > 50 × 109/L), and adolescents (age 16 to 20 years), young adults (age 21 to 39 years), adults (age 40 to 59 years), and older adults (age 60 to 86 years) with ALL. Other, B-cell ALL lacking recurrent abnormalities; Ph, Philadelphia chromosome. Data adapted. Reprinted from Iacobucci and Mullighan with permission.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal